Indeed, in murine models, blocking of NOX4 not only allows for the inhibition of new CAF formation but also the reversion of already “differentiated” CAFs, allowing better response to iCPI by for example enhancing the penetration of CD8+ T cells within tumor cells [41]. The gene discussed is CD8A; the disease is neoplasm.